Researchers identify GPNMB as a driver of Parkinson’s disease spread and demonstrate that monoclonal antibodies can block its activity to slow neurodegeneration.
In particular, Umemori’s lab has confirmed the role a new molecule in this step: signal regulatory protein-alpha. SIRP-alpha travels between pre- and post-synaptic neurons, binding with specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results